Modeling experimental glaucoma for screening studies of antiglaucomatous activity
Introduction: In vivo screening studies, in which the efficacy of dozens of drugs is tested to select several applicants for further study of their safety in humans, are the main stage in the study of the pharmacodynamics of promising antiglaucoma drugs. This imposes a number of specific requirement...
Saved in:
Main Authors: | Vladimir N. Fedorov (Author), Mikhail K. Korsakov (Author), Vladimir P. Vdovichenko (Author), Salavat S. Suleimanov (Author), Alena N. Tyushina (Author), Anastasiya A. Popova (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacotherapy of glaucoma in terms of evidence-based medicine
by: V. N. Fedorov, et al.
Published: (2023) -
Treatment of hepatitis induced by anti-tuberculosis drugs (experimental research)
by: Vladimir N. Fedorov, et al.
Published: (2020) -
Screening of anti-inflammatory activity of 4.5-dihydroisoxazol-5-carboxamide (PAR-2 inhibitors) based on formaldehyde oedema model among white lab rats
by: Mikhail K. Korsakov, et al.
Published: (2023) -
Direct Inhibition of N-Methyl-D-Aspartate (NMDA)-Receptor Function by Antiglaucomatous β-Antagonists
by: Tatsuo Nagata, et al.
Published: (2008) -
Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model
by: Can N, et al.
Published: (2015)